• Preclinical in vivo validation of the RAD51 test for identification of homologous recombination-deficient tumors and patient stratification.
    • Pellegrino B, Herencia-Ropero A, Llop-Guevara A, Pedretti F, Moles-Fernández A, Viaplana C, Villacampa G, Guzman M, Rodriguez O, Grueso J, Jimenez J, Arenas EJ, Degasperi A, Lopes. Dias JM, Forment JV, O'Connor MJ, Déas O, Cairo S, Zhou Y, Musolino A, Caldas C, Nik-Zainal S, Clarke RB, Nuciforo PG, Díez O, Serres-Créixams X, Peg V, Espinosa-Bravo M, Macarulla T, Oaknin A, Mateo J, Arribas J, Dienstmann R, Bellet M, Oliveira M, Saura C, Gutiérrez-Enríquez S, Balmaña J, Serra V.
    • Cancer Res. 2022 Feb 16:canres.2409.2021. doi: 10.1158/0008-5472.CAN-21-2409. Epub ahead of print.